Laddar...
Improving DNA Vaccine Potency by Linking Marek's Disease Virus Type 1 VP22 to an Antigen
We have previously employed an intercellular spreading strategy using herpes simplex virus type 1 (HSV-1) VP22 protein to enhance DNA vaccine potency because DNA vaccines lack the intrinsic ability to amplify in cells. Recently, studies have demonstrated that the protein encoded by UL49 of Marek...
Sparad:
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Society for Microbiology
2002
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC135982/ https://ncbi.nlm.nih.gov/pubmed/11861834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.76.6.2676-2682.2002 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|